CANCRO DA PRÓSTATA | Porto, Portugal | Instituto de Terapia Focal

PROSTATE CANCER

It is the most frequent tumor. Annually about 417 thousand new cases / year are diagnosed in Europe. It represents the 3rd cause of death from cancer pathology.

1 in 7 European men will suffer from this disease.
The incidence has always been increasing for the past 20 years.

THE DIAGNOSIS

Currently, the suspicion arises with a high PSA value, however, the diagnosis is only confirmed with a positive biopsy for malignant cells - Prostate cancer is always asymptomatic, in the initial phase. (The presence of urinary symptoms may mean BPH ).

CLASSICALLY

HIGH PSA

RANDOM TRANSRECTAL PROSTATIC BIOPSY

(6-12 FRAG.)

NMR STAYING

SURGERY

RADIOTHERAPY

THE NEW PARADIGM

HIGH PSA

MULTIPARAMETRIC NMR

TRANSPERINEAL FUSION BIOPSY

VIGILÂNCIA ACTIVA

TERAPIA FOCAL

SURGERY

RADIOTHERAPY

• Multiparametric Magnetic Resonance (NMR) allows the location of the tumor (s) to be reliably located. When its result is normal, clinically significant Prostate Cancer is very unlikely (negative predictive value in the order of 95%).

• Transperineal fusion biopsy uses a matrix system with 5mm intervals, which allows not only an accurate three-dimensional location, but also a perfect classification. It is based on an augmented reality system in which the NMRmp image is superimposed on the ultrasound image in real time. Because it is not transrectal, the infection rate is virtually zero.

Note - Currently, many tumors are treated by adopting a focal strategy: breast, kidney, for example. The advantages of this approach relate to a much faster post-treatment recovery and practically zero side effects. Diagnostic technique is essential to accurately identify the focus to be treated.